EASD: European Association for the Study of Diabetes

News

DPP-4 Inhibitors May Be Cardioprotective

Major Finding: Type 2 diabetes patients taking DPP-4 inhibitors had a statistically significant 31% reduced incidence of cardiovascular events,...

Pages